As of 2025-07-07, the Fair Value of Axsome Therapeutics Inc (AXSM) is -28.26 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 105.44 USD, the upside of Axsome Therapeutics Inc is -126.80%.
With the market price of 105.44 USD and our fair value calculation, Axsome Therapeutics Inc (AXSM) is not a good investment. Investing in Axsome stocks now will result in a potential loss of 126.80%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -102.90 | -130.40 | -187.13 | -239.24 | -287.22 | -189.38 |
| YoY growth | -50.55% | -26.72% | -43.50% | -27.85% | -20.05% | -33.74% |
| Market Cap (mil) | 5,191.87 |
| P/E | |
| Forward P/E |
| EPS | -5.65 |
| Avg earnings growth rate | -33.74% |
| TTM earnings | -278.27 |